UK High Court of Justice Rules Endocuff® and Endocuff Vision® Patents and Design Rights to be Valid and Infringed

AMSTERDAM, February 23, 2018 /PRNewswire/ --

Arc Medical Design Limited, a subsidiary of Norgine B.V., today announced that the High Court of Justice England and Wales, Patents Court ruled that ENDOCUFF^® and ENDOCUFF VISION^® UK national and UK(EP) patents (as amended) are valid and infringed by Cantel's AmplifEYE^® endoscopic device, and key design rights are valid and infringed by AmplifEYE^®. The patent and design rights had been challenged by Cantel Medical (UK) Limited and Cantel (UK) Limited.

     (Logo: http://mma.prnewswire.com/media/597589/Norgine_Logo.jpg )

Peter Martin, COO of Norgine and Chair of the Arc Medical Design Limited Board said: "We welcome the judgement and our resounding success, recognising the strong protection for both ENDOCUFF^® and ENDOCUFF VISION^®. This decision validates our confidence in the intellectual property portfolio protecting our products. We will always vigorously defend our intellectual property and will initiate legal proceedings where appropriate."

ENDOCUFF VISION^® is a single use device attached at the end of the colonoscope that gives an optimal view of the entire colon by retracting folds during withdrawal.

Notes to Editors:  

About the UK Case No. HP-2016-000047 

On Friday 23 February 2018 the High Court of Justice England and Wales, Patents Court ruled that:Arc Medical Design Limited won on all counts:

• Arc Medical Design Limited's ENDOCUFF and ENDOCUFF VISION UK national patent 2478081 and UK(EP) patent 2575590, as amended, are valid and infringed;
• its ENDOCUFF VISION Registered Community Design 002523191-0001 is valid and infringed, its ENDOCUFF Registered Community Design 001856121-0001 is valid but not infringed; and
• its UK unregistered design rights in ENDOCUFF and ENDOCUFF VISION will be infringed from the date of the judgment.
• The judgment is for the UK market.

View the full media release on http://www.norgine.com/media

Media Contact: 

Isabelle Jouin, T: +44 (0)1895 453643

Follow us @norgine